>
Switch to:

Cullinan Oncology EV-to-EBITDA

: (As of Today)
View and export this data going back to 2021. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cullinan Oncology's enterprise value is $582.89 Mil. Cullinan Oncology does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Dec. 2019. Therefore, GuruFocus does not calculate Cullinan Oncology's EV-to-EBITDA at this moment.

The historical rank and industry rank for Cullinan Oncology's EV-to-EBITDA or its related term are showing as below:

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2021-10-20), Cullinan Oncology's stock price is $21.51. Cullinan Oncology does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2019. Therefore, GuruFocus does not calculate Cullinan Oncology's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Cullinan Oncology EV-to-EBITDA Historical Data

The historical data trend for Cullinan Oncology's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cullinan Oncology Annual Data
Trend Dec18 Dec19 Dec20
EV-to-EBITDA
- - -

Cullinan Oncology Semi-Annual Data
Dec18 Dec19 Dec20
EV-to-EBITDA - - -

Competitive Comparison

For the Biotechnology subindustry, Cullinan Oncology's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Cullinan Oncology EV-to-EBITDA Distribution

For the Biotechnology industry and Healthcare sector, Cullinan Oncology's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cullinan Oncology's EV-to-EBITDA falls into.



Cullinan Oncology EV-to-EBITDA Calculation

Cullinan Oncology's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=582.885/
=


Cullinan Oncology  (NAS:CGEM) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Cullinan Oncology's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=21.51/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Cullinan Oncology EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cullinan Oncology's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Cullinan Oncology Business Description

Cullinan Oncology logo
Industry
Healthcare » Biotechnology NAICS : 541713 SIC : 2834
Comparable Companies
Traded in Other Exchanges
N/A
Address
One Main Street, Suite 520, Cambridge, MA, USA, 02142
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Cullinan Oncology Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)